Detalhe da pesquisa
1.
Expert review on soft-tissue plasmacytomas in multiple myeloma: definition, disease assessment and treatment considerations.
Br J Haematol
; 194(3): 496-507, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33724461
2.
Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial.
Lancet
; 396(10262): 1563-1573, 2020 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33189178
3.
A multicenter retrospective study of 223 patients with t(14;16) in multiple myeloma.
Am J Hematol
; 95(5): 503-509, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32072687
4.
Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma.
N Engl J Med
; 375(8): 754-66, 2016 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27557302
5.
Zoledronic acid as compared with observation in multiple myeloma patients at biochemical relapse: results of the randomized AZABACHE Spanish trial.
Haematologica
; 100(9): 1207-13, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26069291
6.
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN).
Blood
; 118(17): 4519-29, 2011 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-21841166
7.
Effect of prior treatments on selinexor, bortezomib, and dexamethasone in previously treated multiple myeloma.
J Hematol Oncol
; 14(1): 59, 2021 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33849608
8.
Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation.
Blood
; 112(10): 4017-23, 2008 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18669875
9.
BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML).
Ann Hematol
; 89(5): 453-8, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19943049
10.
P53 deletion may drive the clinical evolution and treatment response in multiple myeloma.
Eur J Haematol
; 84(4): 359-61, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20002730
11.
Plasma Cell Leukemia - Facts and Controversies: More Questions than Answers?
Clin Hematol Int
; 2(4): 133-142, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34595454
12.
A Next-Generation Sequencing Strategy for Evaluating the Most Common Genetic Abnormalities in Multiple Myeloma.
J Mol Diagn
; 19(1): 99-106, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27863261
13.
Positive selection for CD34+ reduces the incidence and severity of veno-occlusive disease of the liver after HLA-identical sibling allogeneic peripheral blood stem cell transplantation.
Exp Hematol
; 31(6): 545-50, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12829031
14.
Late differentiation syndrome in acute promyelocytic leukemia: a challenging diagnosis.
Hematol Rep
; 6(4): 5654, 2014 Nov 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25568763
15.
Prognostic value of immunophenotyping in multiple myeloma: a study by the PETHEMA/GEM cooperative study groups on patients uniformly treated with high-dose therapy.
J Clin Oncol
; 26(16): 2737-44, 2008 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18443352
16.
Methylenetetrahydrofolate reductase genotype does not play a role in multiple myeloma pathogenesis.
Br J Haematol
; 117(4): 890-2, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12060127
17.
Influence of the different CD34+ and CD34- cell subsets infused on clinical outcome after non-myeloablative allogeneic peripheral blood transplantation from human leucocyte antigen-identical sibling donors.
Br J Haematol
; 119(1): 135-43, 2002 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-12358918
18.
Methylation is an inactivating mechanism of the p16 gene in multiple myeloma associated with high plasma cell proliferation and short survival.
Br J Haematol
; 118(4): 1034-40, 2002 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12199782
19.
Cyclophosphamide, pegylated liposomal doxorubicin (Caelyx), vincristine and prednisone (CCOP) in elderly patients with diffuse large B-cell lymphoma: results from a prospective phase II study.
Haematologica
; 87(8): 822-7, 2002 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-12161358
20.
The composition of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization regimen.
Transfusion
; 42(9): 1159-72, 2002 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-12430673